Omnicell | Sustainability Performance
Develops automated medication management solutions, offering products and services to enhance efficiency and safety in healthcare settings.
1992
United States
1,001 - 5,000 employees
Medical Device
$1B - 10B in revenue
$1M - 10M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4869
Overallⓘ#1004
in United Statesⓘ#80
in Medical DeviceⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Governance
TargetsFinancial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Omnicell Inc, US pharmacy automation, suffered a major 2022 ransomware cyberattack disrupting US hospital pharmacy customer operations including supply chain access for thousands of US hospitals, plus the contested 2024 sustained share price decline amid US hospital pharmacy customer demand normalization affecting institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
7-10
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.